BANGALORE (Reuters): Moderna said on Wednesday (Aug 5) it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has received about US$400 million in deposits for potential supply.
Last week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine is safe and effective, the final hurdle prior to regulatory approval. It has said the vaccine could be ready for widespread use by the end of this year.
"As we pivot to a commercial stage company, we recognise the need for responsible pricing in the face of the pandemic," Chief Executive Officer Stéphane Bancel said.
As much as we are hoping for a silver bullet or vaccine to bring an end to today's Covid problem, but we should not risk the long term effect of unproven vaccine esp. healthy people. Please read above "We can’t skip steps on the road to a COVID-19 vaccine" by theeverge. Even a new car development would take years. Don't be mislead by those clueless leaders who wanted to mislead us to stay in power. Take a balance view on the situation and don't treat share market as gambling den. Take a more informed approach. Share price is already high and risk of collapsing is high esp. there is no proven solution yet. It is still not too late to jump in when the trend started, just that you may only miss the low point (and if that really happened). Worst case, there would not be a safe and reliable vaccine.
Please understand that scientist do not fully understand Covid and whether the antibody does really give adequate protection against Covid. Scientist discover something new every month. How notorious it is, how it attacks our body (or specific organ), lasting effect, how contagious it is, how aggressive it mutated, etc, etc. For now, kindly adopt the new norm instead of hoping a clueless attempt to bring an end to this crisis instantly. The Covid is too widespread, the efficacy of vaccine may be only 40% to 60% like the flu shot (thus need to be taken every year and that is not mandatory but optional).
BEIJING, Aug. 6 (Xinhua) -- A production workshop for inactivated COVID-19 vaccines in Beijing has passed biosafety inspection and is qualified for use, according to the China National Biotec Group (CNBG).
The latest news reports in the United States pointed out that the vaccine may not be effective for obese people!
Are many obese people in the world unable to be vaccinated? hahaha
Glove stocks will be very popular!
Careplus has three advantages. 1) With the cooperation of Ansell, a major Australian medical company, there will be great development in the future. 2) There are production gloves and masks, etc. 3) The business is not only in the United States, but also in South American countries and so on!
To all current shareholders of pharma. Try to read these articles. I joined pharma during April and after this article boost my confidence to hold long. And of course in the midway I am taking profit. But when the price slow down, I added again so that I won't regret.haha.
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
MQ Trader 713 views | 3 d ago
0:17
New IPO: An enterprise IT solutions provider that provides implementation services, maintenance, support and professional services, Vetece Holdings Bhd aims to list on the Ace Market!
MQ Trader 678 views | 7 d ago
0:17
New IPO: A manufacturing and trading of biomass fuel products, particularly PKS and wood pellets company, Elridge Energy Holdings Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
targetinvest
2,646 posts
Posted by targetinvest > 2020-08-06 00:27 | Report Abuse
Even during PH administration.. Pharma contract also got extended becuz they dun want to disrupt supply